Previous close | 57.95 |
Open | 57.95 |
Bid | 57.20 |
Ask | 66.00 |
Strike | 400.00 |
Expiry date | 2025-01-17 |
Day's range | 57.95 - 57.95 |
Contract range | N/A |
Volume | |
Open interest | 191 |
Crispr stock is down for the fifth straight week as the top Cathie Wood's holding struggles amid dim expectations for its gene-editing drug.
In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $416.03, indicating a +0.09% shift from the previous trading day.
While CF remains the main area of focus for Vertex Pharmaceuticals (VRTX), it is seeing success in the development of its non-CF pipeline candidates.